s, and 360 patents, and edited 12 books. He has also received over 80 major awards including the Gairdner Foundation International Award, Lemelson-MIT prize, ACS’s Applied Polymer Science and Polymer Chemistry Awards, AICHE’s Professional Progress, Bioengineering, Walker and Stine Materials Science and Engineering Awards. In 1989, Dr. Langer was elected to the Institute of Medicine of the National Academy of Sciences, and in 1992 he was elected to both the National Academy of Engineering and the National Academy of Sciences. He is the only active member of all three National Academies. Kevin Shakesheff was born in Ashington, Northumberland, U.K., in 1969. He received his Bacheclor of Pharmacy degree from the University of Nottingham in 1991 and a Ph.D. from the same institution in 1995. In 1996 he became a NATO Postdoctoral Fellow at MIT, Department of Chemical Engineering. He is currently an EPSRC Advanced Fellow at the School of Pharmaceutical Sciences, The University of Nottingham. His research group investigates new methods of engineering polymer surfaces and the application of these engineered materials in drug delivery and tissue engineering. 3182 Chemical Reviews, 1999, Vol. 99, No. 11 Uhrich et al.
[1]
Kinam Park,et al.
Controlled drug delivery : challenges and strategies
,
1997
.
[2]
S. Shalaby,et al.
Biomedical polymers : designed-to-degrade systems
,
1994
.
[3]
A. Domb.
Polymeric site-specific pharmacotherapy
,
1994
.
[4]
F. Silver,et al.
Tissue compatibility of tyrosine-derived polycarbonates and polyiminocarbonates: an initial evaluation.
,
1992,
Journal of long-term effects of medical implants.
[5]
R. Langer,et al.
Biodegradable polymers as drug delivery systems
,
1990
.
[6]
David S. Dresback.
Controlled Release Delivery Systems
,
1983
.
[7]
V. Calhoun,et al.
Controlled release of bioactive materials.
,
1980
.